A comprehensive review of the safety and efficacy of COVID-19 vaccines entitled “A Time of COVID” dated 9 August has been widely distributed both nationally and internationally.  Dr. Altman frequently appears in various website interviews and has published widely on COVID, the COVID vaccines and COVID treatment.

Dr. Altman is a well-known Australian authority on clinical trials and regulatory affairs with more than 40 years of experience in designing, managing and reporting of clinical trials and in working with the Australian Therapeutic Goods Administration in gaining new drug approvals. He has worked in senior managerial positions for several multinational companies including Merrell-Dow, Hoechst, Roussel and GD Searle. He established Australia’s first contract research organisations (CROs), where he served as a Senior Industry Consultant for more than half of the pharmaceutical companies present in Australia. His career has seen him involved in more than one hundred clinical trials (Phase I through IV). He has been personally responsible for the market approval of numerous new drugs since joining the pharmaceutical industry in 1974.

Dr.Altman has a comprehensive working knowledge of the international

pharmaceutical standards and guidelines involved in all aspects of drug development including drug manufacture, animal and clinical safety and efficacy testing.  

A graduate of Sydney University with an Honours degree in Pharmacy, Master of Science and Doctor of Philosophy degrees (focusing on drug development, pharmacology and pharmaceutical chemistry), he co-founded and is a Life Member of the largest professional body of pharmaceutical industry scientists involved in clinical research and regulatory affairs (Association of Regulatory and Clinical Scientists to the Australian Pharmaceutical Industry Ltd. - ARCS). ARCS presently has more than 2000 members.   More recently Dr. Altman was a Director and the chief clinical trial and regulatory advisor for a public company involved in the development of a live virus for the treatment of late stage melanoma.

Dr.Altman has presented to the Cross Party Covid Inquiry held in Brisbane and has provided expert reports in relation to both the Australian and NZ Judicial Review and High Court cases in relation to the Covid vaccines.  


Doctor Phillip Altman
Bachelor of Pharmacy, B.Sc., M.Sc., Ph. D
Feb 2023
still at 6.30pm sharp
The venue has changed from the RSL at Mittagong as it is doing renovations to the Carrington Room and Joadja room so the talk by Philip Altman is moved to the Moss Vale RSL


No items found.

Past Lectures

Nov 2023
Space Sciences
Professor Anatoly Rozenfeld
Nov 2023
“Secrets of cultural heritage revealed at ANSTO”
Dr Joseph Bevitt Senior Instrument Scientist ANSTO
Oct 2023
“Are our weeds becoming new native species?”
Professor Angela Moles FRSN Ecology and Evolution Research Centre UNSW Sydney
Aug 2023
Jul 2023
“A recent study of nuclear energy usage in Canada and the USA”
Mr. Robert Parker Founder Nuclear For Climate Australia
View all Past Lectures